high adoption rates in emerging market.
Growing Incidence of Arrhythmia and Heart Failure
In Europe and North America, 1-2% of the total healthcare expenditure is attributed to heart failure. In 2016, around 5.5 million people were diagnosed with heart failure in the United States. It is expected that this number would become 8 million by 2030. Since electrophysiology devices has their major applications in detecting the heart failure rates, the increasing cases of heart failures are expected to drive the market in the forecast period.
In addition, rapid growth in ageing population is responsible to increase heart failure rates which is further attributed to contribute in the growth of global electrophysiology market.
Lack of Skilled and Experienced Electro physiologists
As of 2017, in the United States, approximately 6-8% of cardiologists hold a specialization in electrophysiology. Although not a favorable percentage, the EP workforce is more or less stable in the United States. However, due to lack of mobility among the majority of established electro physiologist, there exists a distinct lag in geographical dispersion of the EPs, resulting in a rift between the demand and supply, and a visible disparity among electro physiologists. These lack of skilled electro physiologists is acting as a major restraint for the global electrophysiology market.
Additionally, unfavorable healthcare reforms along with lack of proper reimbursement policies are also responsible for hindering the growth of the market.
North America to Dominate the Market
The electrophysiology market is segmented by product type, and geography. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.
North America dominates the electrophysiology market due to the presence of well-established healthcare facilities and rise in number of arrhythmia and heart failure cases in the region. Asia-Pacific is also expected to propel the electrophysiology market owing to factors, such as increasing accessibility to healthcare facilities in the region, rising medical tourism, and increasing incidences of heart failure cases.
Key Developments in the Market
- January 2018: BioSig Technologies, a medical device company which is developing a biomedical signal processing platform designed to address the demand for electrophysiology market has partnered with Mr. Charles Austin and JK advisors to scale up operational activities.
- January 2018: Rhythmlink announced patent license agreement with Dignity Health for improving and expanding brain health monitoring options. The proprietary technology by Dignity Health allows quick and easy collection of EEG data which can be further distributed to healthcare personnel for analysis and intervention.
Reasons to Purchase this Report
- Market analysis for the Global electrophysiology Market, with region-specific assessments and competition analysis on a global and regional scale.
- Analyzing various perspectives of the industry with the help of Porter’s five forces analysis
- The treatment type that is expected to dominate the market
- Regions that are expected to witness fastest growth during the forecast period
- Identify the latest developments, market shares and strategies employed by the major market players.
- 3 months analyst support along with the Market Estimate sheet in excel.
This report can be customized to meet your requirements..
1.1 MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW
5.1 CURRENT MARKET SCENARIO
5.2 PORTER'S FIVE FORCES ANALYSIS
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF CONSUMERS
5.2.3 THREATS OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 GROWING INCIDENCE OF ARRHYTHMIA AND HEART FAILURE
6.1.2 HIGH ADOPTION RATES IN EMERGING MARKETS DUE TO TECHNOLOGICAL ADVANCEMENTS
6.1.3 RAPID GROWTH IN AGING POPULATION
6.1.4 INCREASING DEMAND FOR CATHETER ABLATION PROCEDURES
6.2 MARKET RESTRAINTS
6.2.1 LACK OF SKILLED AND EXPERIENCED ELECTROPHYSIOLOGISTS
6.2.2 UNFAVORABLE HEALTHCARE REFORMS
6.4 KEY CHALLENGES
7. Market Segmentation
7.1 SEGMENTATION-BY PRODUCTS
7.1.1 ELECTROPHYSIOLOGY MONITORING DEVICES
188.8.131.52 ELECTROCARDIOGRAPH (ECG)
184.108.40.206 ELECTROENCEPHALOGRAPH (EEG)
220.127.116.11 ELECTROCORTICOGRAPH (ECOG)
18.104.22.168 ELECTROMYOGRAPH (EMG)
22.214.171.124 ELECTRORETINOGRAPH (ERG)
126.96.36.199 ELECTROOCULOGRAPH (EOG)
7.1.2 HOLTER MONITORING DEVICES
188.8.131.52 X-RAY SYSTEMS
184.108.40.206 IMAGING AND 3D MAPPING SYSTEMS
220.127.116.11 DIAGNOSTIC ELECTROPHYSIOLOGY CATHETERS
7.1.3 ELECTROPHYSIOLOGY TREATMENT DEVICES
18.104.22.168 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS)
22.214.171.124 CARDIAC RESYNCHRONIZATION THERAPY DEVICES (CRTS)
126.96.36.199.1 RADIOFREQUENCY ELECTROPHYSIOLOGY ABLATION CATHETERS
188.8.131.52.2 CRYOABLATION ELECTROPHYSIOLOGY CATHETERS
184.108.40.206.3 LASER ABLATION CATHETERS
220.127.116.11.4 MICROWAVE ABLATION CATHETERS
7.2 SEGMENTATION-BY GEOGRAPHY
7.2.1 NORTH AMERICA
18.104.22.168 UNITED STATES
22.214.171.124 UNITED KINGDOM
126.96.36.199 REST OF EUROPE
188.8.131.52 AUSTRALIA & NEW ZEALAND
184.108.40.206 SOUTH KOREA
220.127.116.11 REST OF ASIA-PACIFIC
7.2.4 MIDDLE EAST & AFRICA
18.104.22.168 SOUTH AFRICA
22.214.171.124 REST OF THE MIDDLE EAST & AFRICA
7.2.5 SOUTH AMERICA
126.96.36.199 REST OF SOUTH AMERICA
8. COMPETITIVE LANDSCAPE
8.1 MERGERS & ACQUISITION ANALYSIS
8.2 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
8.3 NEW PRODUCTS LAUNCHES
9. KEY PLAYERS
9.1 ABBOTT LABORATORIES
9.2 BOSTON SCIENTIFIC
9.3 BIOTRONIK SE & CO. KG
9.4 GE HEALTHCARE
9.5 HANSEN MEDICAL
9.6 JOHNSON & JOHNSON
9.7 MEDTRONIC INC.
9.8 SIEMENS HEALTHCARE
9.9 NIHON KOHDEN CORPORATION
10. FUTURE OF THE MARKET